LeenLife Pharma International Inc. — Form D
LeenLife Pharma International Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-20. The offering totals $124K, of which $124K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-12-20
- Form: D
- Accession: 0001725612-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $124K
- Amount sold: $124K
- Investors: 4
- Date of first sale: 2017-12-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-301202
Issuer
- Name: LeenLife Pharma International Inc.
- CIK: 0001725612
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2014
- Address: SUITE 380-580 HORNBY STREET, VANCOUVER, A1, V6C3B6
- Phone: 778-688-1799
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Marcin Lukaszewcz | Director | Vancouver, A1 |
| Casey Forward | Executive Officer | Vancouver, A1 |
| Marcin Lukaszewcz | Executive Officer | Vancouver, A1 |
More